Literature DB >> 29764195

Eremophilane sesquiterpenes from the endophytic fungus Xylaria sp. GDG-102.

Yan Liang1, Weifeng Xu1, Chengmei Liu1, Dexiong Zhou1, Xiaobo Liu1, Yuyue Qin1, Fei Cao2, Jun Li1, Ruiyun Yang1, Jiangke Qin1.   

Abstract

A new eremophilane sesquiterpene, xylareremophil (1), together with five known eremophilanes, 1α,10α-epoxy-3α-hydroxyeremophil-7(11)-en-12,8β-olide (2), 1,10α,13-trihydroxyeremophil-7(11)-en-12,8-olide (3), 1α,10α-epoxy-13-hydroxyeremophil-7(11)-en-12,8β-olide (4), mairetolides B (5) and G (6) were isolated from the endophytic fungus Xylaria sp. GDG-102 cultured from Sophora tonkinensis. Their structures were elucidated on the basis of spectroscopic data analysis. The absolute configurations of 1 was determined by comparing computed electronic circular dichroism (ECD) and optical rotation (OR) with experimental results. Compounds 1, 5 and 6 showed antibacterial activities against Proteus vulgaris, Micrococcus luteus, Micrococcus lysodeikticus and Bacillus subtilis with MIC values of 25-100 μg/mL.

Entities:  

Keywords:  sp; Endophytic fungus; antibacterial activity; sesquiterpene

Mesh:

Substances:

Year:  2018        PMID: 29764195     DOI: 10.1080/14786419.2018.1472597

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  3 in total

Review 1.  Fungal Endophytes: A Potential Source of Antibacterial Compounds.

Authors:  Sunil K Deshmukh; Laurent Dufossé; Hemraj Chhipa; Sanjai Saxena; Girish B Mahajan; Manish Kumar Gupta
Journal:  J Fungi (Basel)       Date:  2022-02-08

Review 2.  Biological Activities and Secondary Metabolites from Sophora tonkinensis and Its Endophytic Fungi.

Authors:  Jia-Jun Liang; Pan-Pan Zhang; Wei Zhang; Da Song; Xin Wei; Xin Yin; Yong-Qiang Zhou; Xiang Pu; Ying Zhou
Journal:  Molecules       Date:  2022-08-29       Impact factor: 4.927

Review 3.  Recent progress in biodiversity research on the Xylariales and their secondary metabolism.

Authors:  Kevin Becker; Marc Stadler
Journal:  J Antibiot (Tokyo)       Date:  2020-10-23       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.